SELECT-LIFE：SELECT心血管アウトカム試験に参加した人々におけるセマグルチドの長期的影響を調査する研究

基本情報

NCT ID

NCT04972721

ステータス

募集中

試験のフェーズ

-

試験タイプ

観察

目標被験者数

3,400

治験依頼者名

Novo Nordisk A/S

概要

Participants are being asked to participate in SELECT-LIFE study because participants take part in the SELECT trial. SELECT-LIFE study is a survey-based study that will start when the SELECT trial ends. SELECT-LIFE looks at the long-term effects of participants taking part in the SELECT trial including the trial medicine participants have been taking. When the SELECT trial ends, participants will no longer get the medicine participants got in the study, even if participants decide to take part in the SELECT-LIFE study. Participants will not get any specific treatment or medicine as part of the SELECT-LIFE study, and participants will be treated as participants normally would by their own doctor. The SELECT-LIFE study will last for up to 10 years after SELECT trial ends, and participants will be asked to fill in a questionnaire about their health every 6 months.

対象疾患

介入

依頼者（Sponsor）

実施施設 (1)